Fairvalue-Calculator Fairvalue-Calculator
EN DE

ShareHope Medicine Co (8403) Fair Value & Analysis

Healthcare · TW · Market cap 2.7B TWD

Price19.25 TWD
Fair Value22.65 TWD
Upside+17.7%
Quality86/100
Evidence: Medium Range 16.99 TWD – 28.32 TWD

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

ShareHope Medicine Co (8403) currently trades at 19.25 TWD, while our model-based Fair Value estimate is 22.65 TWD — implying the stock looks roughly 17.7% undervalued today. We read business quality at 86/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

About the company

ShareHope Medicine Co., Ltd. provides integrated medical services in Taiwan. The company is involved in health management and operation activities; human resource dispatch of professional medical staff services. It also offers provision of medical, pharmaceutical, and health devices, as well as long-distance health care services; and rental of medical devices. ShareHope Medicine Co., Ltd. was founded in 2003 and is based in Taoyuan City, Taiwan.

Open the full interactive analysis →

Similar stocks

McKesson Corporation (M1CK34) +22% Cencora, Inc (C1CO34) -44% Cardinal Health, Inc (CAH) -49% Sigma Healthcare Limited (SIGGF) -67% Sitka Gold Corp (SIG) -88% Shanghai Pharmaceuticals Holding (601607) +112%

Frequently asked questions

Is ShareHope Medicine Co (8403) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 22.65 TWD versus a price of 19.25 TWD — about +18% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 8403?
Our 21-model fair value for ShareHope Medicine Co is 22.65 TWD (as of Jun 24, 2026), built from audited fundamentals. The current price is 19.25 TWD.
What is the quality score of 8403?
ShareHope Medicine Co has a Quality Score of 86/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.